Skip to content

Net margin at other companies

HRO
HarrowHROW
-19.8%+18.0pp
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
101.6%+60.1pp
XER
Xeris Biopharma Holdings, Inc.XERS
3.8%+2.1pp
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-90.9%-2.1pp
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
10%+8.1pp
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
-2,747.2%-1,328pp

Other financials

Income statement

See full
Revenue$24.3M+40.4%
Gross profit$14.7M+49.4%
Operating income$2.4M+614%
Net income$1.6M+199%
EPS (diluted)$0.05+183%

Balance sheet

See full
Cash & equivalents$19.7M+12.9%
Total debt$31.3M+3.7%
Total equity$30.6M+25.2%
Total assets$97.7M+16.3%

Cash flow

See full
Operating cash flow$7.4M+254%
CapEx$75.0K
Free cash flow$7.3M+251%

Valuation

See full
Market cap$930.79M+156%
Enterprise value$942.39M+150%
P/S10.7×+3.2×

Profitability

See full
Gross margin54.8%-3.7pp
Operating margin-15.1%
FCF margin17.1%

Returns & leverage

See full
Return on equity-34.2%+0.9pp
Debt / equity-0.2×
Current ratio1.2×-0.8×

Where this comes from

Calculated from Eton Pharmaceuticals, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Eton Pharmaceuticals, Inc.’s 10-Q, filed November 6, 2025, on SEC EDGAR. View the filing →

Ask your AI about Eton Pharmaceuticals, Inc.'s net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Eton Pharmaceuticals, Inc.'s net margin?
Eton Pharmaceuticals, Inc. (ETON) reported net margin of -9.5% in Q3 2025.
How has Eton Pharmaceuticals, Inc.'s net margin changed year-over-year?
Eton Pharmaceuticals, Inc.'s net margin increased by 39.9% year-over-year, from -15.8% to -9.5%.
What is the long-term trend for Eton Pharmaceuticals, Inc.'s net margin?
Over 2 years (2020 to 2024), Eton Pharmaceuticals, Inc.'s net margin has grown at a -98.8% compound annual growth rate (CAGR), from -71,717.9% to -9.8%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.